SCYX: Wutah bathi EPS kuartalan SCYNEXIS

SCYNEXIS, Inc. (SCYX) has minimized internal costs and created a royalty lever by transitioning to the licensing of antifungal agents to third-party tech giants. The quarterly relative change in EPS captures this effect, with the parameter mark equal to 48.20. Management stability is ensured by the partnership with GSK and revenue transparency, while the company simultaneously expands its antifungal product portfolio for the hospital and pharmacy sectors.

SCYNEXIS Inc (SCYX) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan saka 04.07.2022 nganti 10.11.2026

Ringkesan rincian data analitis SCYNEXIS, Inc. (SCYX)

- rega saham lan prakiraan rega para ahli:

Rega saham scynexis.com|SCYX - Bagan tingkat prakiraan

- informasi kapitalisasi pasar:

Kapitalisasi pasar Scynexis|SCYX - Total Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham SCYNEXIS|SCYX - Aset Bersih Perusahaan|Rasio Kapitalisasi marang Aset Bersih scynexis.com|SCYX - Aset Agregat Bisnis

- data liabilitas lan likuiditas perusahaan:

Total Utang marang Modal SCYNEXIS, Inc.|SCYX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas scynexis.com|SCYX - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Scynexis|SCYX - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan SCYNEXIS|Likuiditas cepet scynexis.com

- indikator bathi lan kelipatan valuasi:

SCYX - Asil keuangan resik|Proyeksi bathi mangsa ngarep SCYNEXIS, Inc.|SCYX - Koefisien rega marang bathi|Prakiraan rega marang bathi scynexis.com|SCYX - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Scynexis|SCYX - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) SCYNEXIS|SCYX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan scynexis.com|SCYX - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep SCYNEXIS, Inc.

Analisis komprehensif perusahaan:SCYNEXIS, Inc.

Quarterly EPS growth measures the rate of change in net income per share, allowing investors to assess capital generation efficiency over the short term. By analyzing quarterly EPS trends, one can compare market demand with actual returns, which for SCYNEXIS, Inc. (SCYX) depend directly on the stability of contract manufacturing for antifungal drugs and the continuity of their supply.

Pesaing wigati